Mike Karim, Medistim's Chief Commercial Officer, has the 7th of November purchased 2211shares form Medistim ASA. This is part of the company long term incentive plan approved by the general meeting the 8th of May 2025. Price per share was NOK 242 and after the purchase Mr. Karim holds 2211 Medistim shares. If in position after 3 years Mr. Karim will receive another 1474 Medistim shares free of charge.
Medistim ASA has sold 2211 shares to Mr. Karim at 242 per share and holds 62032 shares after the sale of shares to Mr. Karim.